Edgewise Therapeutics, Inc. (EWTX)

NASDAQ: EWTX · Real-Time Price · USD

43.18

-0.38 (-0.87%)

At close: Aug 13, 2026, 4:00 PM EDT

42.70

-0.48 (-1.11%)

Pre-market: Aug 14, 2026, 7:50 AM EDT

Edgewise Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-197.22	-167.8	-133.81	-100.16	-67.64	-42.81
Depreciation & Amortization	2.33	2.27	2.29	1.73	0.54	0.27
Stock-Based Compensation	36.04	34.75	24.71	17.56	10.92	4.4
Other Adjustments	-5.36	-7.67	-12.55	-9.52	-0.54	-
Changes in Accounts Payable	-0.21	0.27	1.74	-0.09	0.05	2.65
Changes in Accrued Expenses	8.37	3.07	5.52	2.19	2.57	4.37
Changes in Other Operating Activities	-2.33	-8.71	3.07	-3.66	1.47	-2.39
Operating Cash Flow	-158.38	-143.82	-109.03	-91.95	-52.64	-33.51
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-0.45	-0.26	-1.31	-5.75	-5.55	-0.67
Purchases of Investments	-304.52	-527.23	-477.06	-255.87	-292.39	-288.2
Proceeds from Sale of Investments	471.38	494.69	293.71	364.5	227.36	46.64
Investing Cash Flow	166.4	-32.79	-184.66	102.89	-70.58	-242.23
Issuance of Common Stock	20.89	196.09	249.52	53.33	129.89	186.51
Net Common Stock Issued (Repurchased)	20.89	196.09	249.52	53.33	129.89	186.51
Other Financing Activities	-	-	-0.26	-0.17	-0.25	-0.12
Financing Cash Flow	20.89	196.09	249.25	53.17	129.64	186.38
Net Cash Flow	28.92	19.48	-44.43	64.1	6.43	-89.35
Free Cash Flow	-158.83	-144.07	-110.34	-97.69	-58.18	-34.18
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-1.49	-1.40	-1.19	-1.53	-1.09	-0.91
Levered Free Cash Flow	-189.51	-171.16	-122.51	-105.74	-68.56	-38.58
Unlevered Free Cash Flow	-211.18	-194.77	-147.53	-119.93	-72.58	-38.98

SEC Filings: 10-K · 10-Q